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osting by EAbstract A series of 1-(N-methyl 2a–c and N-benzenesulphonyl-1H-indol-3-yl)-3-aryl-prop-2-ene-
1-ones 3a–c were prepared and allowed to react with urea, thiourea or guanidine and gave the
pyrimidine derivatives 4a–c to 9a–c. Base catalyzed reaction of 2a–c or 3a–c with ethyl acetoacetate
gave cyclohexanone derivatives 10a–c and 11a–c, respectively. Reaction of the latter compounds
with hydrazine hydrate afforded indazole derivatives 12a–c and 13a–c, respectively. On the other
hand, condensation of 2c or 3c with some hydrazine derivatives namely, hydrazine hydrate, acetyl
hydrazine, phenyl hydrazine and benzyl hydrazine hydrochloride gave pyrazole derivatives
14a,b-17a,b, respectively. Moreover, reaction of 2c or 3c with hydroxyl amine hydrochloride gave
isoxazole derivatives 18a,b. The newly synthesized compounds were tested for their antimicrobial
activity and showed that, compounds 14a, 14b, 15a and 15b were found to be the most active ones
of all the tested compounds toward Salmonella typhimurium (ATCC 14,028) compared to the ref-
erence drug chloramphenicol. Eighteen new compounds namely, pyrimidin-2(1H)-ones 4a–c and2604756, mobile: +20 123369
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68 E.R. El-Sawy et al.5a–c, pyrimidin-2(1H)-thiones 6a–c and 7a–c and pyrimidin-2-amines 8a–c and 9a–c were tested for
their in vitro cytotoxicity against human liver carcinoma (HEPG2), human breast cancer (MCF7)
and human colon cancer (HCT-116) cell lines and showed that, compounds 4c, 5c, 6c, 8c and 9c
were found to be the highly active compounds compared to the reference drug doxorubicin.
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Chalcones, one of the major classes of natural products with
widespread occurrence in fruits, vegetables, spices and soy-
based foodstuff, have been reported to possess several bio-
logical activities (Ngameni et al., 2007; Okwu and Ukanwa,
2010). An important feature of chalcones is their ability to
act as an intermediate for the synthesis of biologically active
heterocyclic compounds viz, pyrimidine, cyclohexanone, pyr-
azole and isoxazole derivatives (Aitmambetov and Menlimu-
ratova, 2003; Flefel et al., 2007; Abdel-Rahman1 et al., 2007;
El Shehry et al., 2010; Sreevidya et al., 2010). Additionally,
indole which is the potent basic pharmacodynamic nucleus
has been reported to possess a wide variety of biological
properties viz, anti-inﬂammatory, anti-cancer and antimicro-
bial activities (George et al., 2008; El-Sawy et al., 2009;
Mandour et al., 2007, 2010). Based on the above observation
and in continuation of our search (El-Sawy et al., 2009,
2010; Mandour et al., 2007, 2010) herein, we reported the
synthesis of some new N-substituted sulphonyl-3-indolyl het-
erocycles and evaluating their antimicrobial and anticancer
activities.
2. Experimental
2.1. Chemistry
Melting points were determined in open capillary tubes on an
Electrothermal 9100 digital melting point apparatus (Bu¨chi,
Switzerland) and were uncorrected. Elemental analyses were
performed on a Perkin–Elmer 2400 analyzer (USA) and were
found within ±0.4% of the theoretical values. IR spectra were
recorded on a Perkin–Elmer 1600 FTIR (USA) in KBr disks.
The 1H NMR spectra were measured with a Bruker Avance
digital spectrophotometer 300 MHz in DMSO-d6 and chemi-
cal shifts were recorded in d ppm relative to TMS as internal
stander solvent. Mass spectra (EI) were run at SECTOR-FILD
MS and GC–MS (single-phase) 200 V (50/60 Hz) 30 A (Ger-
many). N-methylsulphonyl (1a) and N-benzenesulphonyl-3-
acetylindoles (1b) have been prepared as reported (Mndzhoyan
et al., 1969).
2.1.1. Synthesis of N-substituted-3-indolylchalcones 2a–c and
3a–c
To a solution of N-substituted-3-acetylindoles 1a or 1b
(0.001 mol) in ethanol (10 mL) containing aqueous potassium
hydroxide solution (5 mL, 25%), the appropriate aldehyde
(0.001 mol) was added. The reaction mixture was stirred for
2 h at room temperature, and then left overnight at refrigera-
tor. The reaction mixture was neutralized with diluted hydro-
chloric acid (1:1) and the solid that formed was ﬁltered off,
washed with water, air dried and recrystallized from absolute
ethanol.2.1.1.1. 1-(N-Methylsulphonyl-1H-indol-3-yl)-3-(m-hydroxy-
phenyl)-prop-2-ene-1-one (2c). Yield 60%, m.p. 90 dec C.
IR (KBr): m 3400 (OH), 1686 (C‚O), 1614 (C‚C), 1342
and 1173 (SO2) cm
1. 1H NMR (300 MHz, DMSO-d6,
25 C, TMS): d = 10.41 (s, 1H, OH), 8.21 (d, 1H, H-2 indole),
7.89–7.32 (m, 8H, ArAH), 7.01 and 6.77 (2d, 2H, CH‚CH),
2.91 (s, 3H, CH3) ppm. Anal. For C18H15NO4S (341.38) calcd:
C 63.33, H 4.43, N 4.10. Found: C 63.19, H 4.55, N 4.22.
2.1.1.2. 1-(N-Benzenesulphonyl-1H-indol-3-yl)-3-(m-hydroxy-
phenyl)-prop-2-ene-1-one (3c). Yield 75%, m.p. 159–61 C.
IR (KBr): m 3320 (OH), 1700 (C‚O), 1617 (C‚C), 1342
and 1175 (SO2) cm
1. 1H NMR (300 MHz, DMSO-d6,
25 C, TMS): d = 12.10 (s, 1H, OH), 8.21 (d, 1H, H-2 indole),
7.89–7.32 (m, 13H, ArAH), 7.01 and 7.22 (2d, 2H, CH‚CH)
ppm. Anal. For C23H17NO4S (403.45), calcd: C 68.47, H 4.25,
N 3.47. Found: C 68.33, H 4.0, N, 3.66.
2.1.2. Synthesis of N-substituted-3-indolylpyrimidin-2(1H)-ones
4a–c and 5a–c
A mixture of chalcones 2a–c or 3a–c (0.01 mol) and urea
(0.6 g, 0.01 mol) in dry ethanol (10 mL) containing glacial ace-
tic acid (0.5 mL) was reﬂuxed for 6–8 h. After cooling, the
reaction mixture was poured onto ice-water (50 mL) and the
solid that formed was ﬁltered off, air dried and recrystallized
from absolute ethanol.
2.1.2.1. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2(1H)-one (4a). Yield 60%, m.p. 163–
5 C. IR (KBr): m 3140 (NH), 1670 (C‚O), 1620 (C‚N),
1575 (C‚C), 1370 and 1167 (SO2), 1009 (CAOAC) cm
1.
1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.90 (s,
1H, NH), 8.21 (s, 1H, H-2 indole), 7.78–7.01 (m, 9H, ArAH),
3.98 (s, 3H, OCH3) 3.32 (s, 3H, CH3) ppm. Anal. For
C20H17N3O4S (395.43) calcd: C 60.75, H 4.33, N 10.63. Found:
C 60.88, H 4.56, N, 10.76.
2.1.2.2. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(p-chloro-
phenyl)-pyrimidin-2(1H)-one (4b). Yield 50%, m.p. 219–
21 C. IR (KBr): m 3414 (NH), 1646 (C‚O), 1602 (C‚N),
1554 (C‚C), 1376 and 1150 (SO2), 745 (CACl) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.98 (s, 1H,
NH), 8.23 (s, 1H, H-2 indole), 7.87–7.21 (m, 9H, ArAH),
3.32 (s, 3H, CH3) ppm. MS, m/z (%): 399 (M
+, 10), 401
(M++2, 3), 144 (100). Anal. For C19H14ClN3O3S (399.85)
calcd: C 57.07, H 3.53, N 10.51. Found: C 57.22, H 3.66, N
10.44.
2.1.2.3. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2(1H)-one (4c). Yield 56%, m.p. 155–
7 C. IR (KBr): m 3400 (OH), 1678 (C‚O), 1612 (C‚N),
1577 (C‚C), 1366 and 1156 (SO2) cm
1; 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 11.21 (s, 1H, OH),
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CHApyrimidine), 7.66–7.12 (m, 8H, ArAH), 3.33 (s, 3H,
CH3) ppm. Anal. For C19H15N3O4S (381.41) calcd: C 59.83,
H 3.96, N 11.02. Found: C 60.00, H 4.00, N 11.32.
2.1.2.4. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2(1H)-one (5a). Yield 55%, m.p. 125–
7 C. IR (KBr): m 3425 (NH), 1635 (C‚O), 1609 (C‚N),
1564 (C‚C), 1384 and 1163 (SO2), 1026 (CAOAC) cm
1.
1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.55 (s,
1H, NH), 8.11 (s, 1H, H-2 indole), 7.99 (s, 1H, CHApyrimi-
dine), 7.78–7.11 (m, 13H, ArAH), 3.98 (s, 3H, OCH3) ppm.
Anal. For C25H19N3O4S (457.5) calcd: C 65.63, H 4.19, N,
9.18. Found: C 65.44, H 4.33, N 9.00.
2.1.2.5. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-chloro-
phenyl)-pyrimidin-2(1H)-one (5b). Yield 48%, m.p. 223–
5 C. IR (KBr): m 3424 (NH), 1641 (C‚O), 1602 (C‚N),
1545 (C‚C), 1395 and 1153 (SO2), 745 (CACl) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 10.21 (s, 1H,
NH), 8.21 (s, 1H, H-2 indole), 7.71–7.01 (m, 14H, ArAH)
ppm. MS, m/z (%): 461 (M+, 12), 463 (M++2, 4), 281
(100). Anal. For C24H16ClN3O3S (461.92) calcd: C 62.34, H
3.49, N, 9.10. Found: C 62.55, H 3.56, N 9.22.
2.1.2.6. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2(1H)-one (5c). Yield 65%, m.p. 97dec
C. IR (KBr, m): 3398 (OH), 3140 (NH), 1670 (C‚O), 1620
(C‚N), 1588 (C‚C), 1370 and 1156 (SO2) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 10.51 (s, 1H, OH),
9.72 (s, 1H, NH), 8.02 (s, 1H, H-2 indole), 7.87–7.23 (m,
14H, ArAH) ppm. MS, m/z (%): 443 (M+, 10), 144 (100).
Anal. For C24H17N3O4S (443.47) calcd: C 65.00, H 3.86, N
9.48. Found: C 65.21, H 3.69, N 9.54.
2.1.3. Synthesis of N-substituted-3-indolylpyrimidin-2(1H)-
thiones 6a–c and 7a–c
A mixture of chalcones 2a–c or 3a–c (0.01 mol) and thiourea
(0.76 g, 0.01 mol) in dry ethanol (10 mL) containing glacial
acetic acid (0.5 mL) was reﬂuxed for 6–8 h. After cooling,
the reaction mixture was poured onto ice-water (50 mL) and
the solid that formed was ﬁltered off, air dried and recrystal-
lized from absolute ethanol.
2.1.3.1. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2(1H)-thione (6a). Yield 50%, m.p. 138–
40 C. IR (KBr): m 3162 (NH), 1615 (C‚N), 1573 (C‚C),
1386 and 1169 (SO2), 1248 (C‚S), 1028 (CAOAC) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.87 (1H, s,
NH), 8.39 (1H, s, H-2 ind.), 8.22 (1H, s, CHApyrimidine),
7.81–7.00 (8H, m, ArAH), 4.32 (3H, s, OCH3), 3.28 (3H, s,
CH3) ppm. MS, m/z (%):411(M
+, 0.01), 277 (100). Anal.
For C20H17N3O3S2 (411.5) calcd: C 58.38, H 4.16, N 10.21.
Found: C 58.42, H 4.30, N 10.44.
2.1.3.2. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(p-chloro-
phenyl)-pyrimidin-2(1H)-thione (6b). Yield 62%, m.p. 169–
71 C. IR (KBr): m 3228 (NH), 1612 (C‚N), 1567 (C‚C),
1378 and 1157 (SO2), 1244 (C‚S), 748 (Cl) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.65 (1H, s,
NH), 8.12 (1H, s, H-2 ind.), 7.65–7.01 (9H, m, ArAH),
3.32 (3H, s, CH3) ppm. MS, m/z (%):415 (M
+, 1), 417(M++2, 0.01), 281 (100). Anal. For C19H14ClN3O2S2
(415.92) calcd: C 54.87, H 3.39, N 10.10. Found: C 54.98,
H 3.22, N 10.00.
2.1.3.3. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2(1H)-thione (6c). Yield 50%, m.p. 79–
81 C. IR (KBr): m 3400 (OH), 3210 (NH), 1645 (C‚N),
1370 and 1167 (SO2), 1240 (C‚S) cm
1; 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 10.54 (s, 1H, OH),
9.51 (1H, s, NH), 8.22 (s, 1H, H-2 indole), 8.00 (s, 1H,
CHApyrimidine), 7.98–7.32 (m, 8H, ArAH), 3.32 (3H, s,
CH3) ppm. Anal. For C19H15N3O3S2 (397.47) calcd: C 57.41,
H 3.80, N 10.57. Found: C 57.22, H 3.67, N 10.43.
2.1.3.4. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2(1H)-thione (7a). Yield 55%, m.p.
155dec C. IR (KBr): m 3300 (NH), 1637 (C‚N), 1608
(C‚C), 1386 and 1161 (SO2), 1250 (C‚S), 1099 and 1029
(CAOAC) cm1. 1H NMR (300 MHz, DMSO-d6, 25 C,
TMS): d = 12.05 (1H, s, NH), 8.31 (1H, s, H-2 ind.), 8.12
(1H, s, CHApyrimidine), 7.79–7.00 (13H, m, ArAH), 4.27
(3H, s, OCH3) ppm. MS, m/z (%):473 (M
+, 0.01), 277 (100).
Anal. For C25H19N3O3S2 (473.57) calcd: C 63.41, H 4.04, N
8.87. Found C 63.56, H 3.99, N 8.90.
2.1.3.5. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-chloro-
phenyl)-pyrimidin-2(1H)-thione (7b). Yield 42%, m.p. 200–
2 C. IR (KBr, m): 3328 (NH), 1641 (C‚N), 1563 (C‚C),
1236 (C‚S), 1395 and 1153 (SO2), 745 (CACl) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.77 (1H, s,
NH), 8.22 (1H, s, H-2 ind.), 7.89–7.01 (14H, m, ArAH)
ppm. MS, m/z (%):477 (M+, 12), 479 (M++2, 2), 115 (100).
Anal. For C24H16ClN3O2S2 (477.99) calcd. C 60.25, H 3.34,
N 8.78. Found: C 60.33, H 3.21, N 8.65.
2.1.3.6. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2(1H)-thione (7c). Yield 68%, m.p. 135–
7 C. IR (KBr): m 3400 (OH), 3218 (NH), 1645 (C‚N), 1577
(C‚C), 1375 and 1167 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 11.51(1H, s, OH), 9.87 (1H, s,
NH), 8.22 (1H, s, H-2 ind.), 7.78–7.01 (14H, m, ArAH)
ppm. MS, m/z (%): 459 (M+, 1), 144 (100). Anal. For
C24H17N3O3S2 (459.54) calcd: C 62.73, H 3.73, N 9.14. Found:
C 62.88, H 3.55, N 9.34.
2.1.4. Synthesis of N-substituted-3-indolylpyrimidin-2-amines
8a–c and 9a–c
A mixture of chalcones 2a–c or 3a–c (0.01 mol), guanidine
hydrochloride (0.96 g, 0.01 mol) and anhydrous sodium ace-
tate (0.82 g, 0.01 mol) in dry ethanol (15 mL) was reﬂuxed
for 2–3 h. After cooling, the solid that formed was ﬁltered
off, air dried and recrystallized from absolute ethanol.
2.1.4.1. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2-amine (8a). Yield 75%, m.p. 148–
150 C. IR (KBr): m 3400 and 3320 (NH2), 1645 (C‚N),
1578 (C‚C), 1368 and 1157 (SO2), 1009 (CAOAC) cm
1.
1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.91 (s,
2H, NH2), 8.02 (s, 1H, H-2 indole), 8.00–7.00 (m, 9H, ArAH),
4.00 (s, 3H, OCH3) 3.33 (s, 3H, CH3) ppm. Anal. For
C20H18N4O3S (394.45) calcd: C 60.90, H 4.60, N 14.20. Found:
C 61.01, H 4.76, N 14.36.
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phenyl)-pyrimidin-2-amine (8b). Yield 85%, m.p. 236–8 C.
IR (KBr): m 3310 and 3218 (NH2), 1645 (C‚N), 1578
(C‚C), 1368 and 1157 (SO2), 746 (Cl) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d 9.99 (s, 2H, NH2),
8.22 (s, 1H, H-2 indole), 8.01–7.21 (m, 9H, ArAH), 3.31 (s,
3H, CH3) ppm. Anal. For C19H15 ClN4O2S (398.87) calcd: C
57.21, H 3.79, N 14.05. Found: C 57.44, H 3.60, N 14.22.
2.1.4.3. 4-(N-Methylsulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2-amine (8c). Yield 79%, m.p. 201–2 C.
IR (KBr): m 3400 (OH), 3218 and 3100 (NH2), 1635 (C‚N),
1566 (C‚C), 1368 and 1157 (SO2) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d 11.65 (s, 2H, OH),
8.21 (s, 1H, H-2 indole), 7.65–7.01 (m, 9H, ArAH), 6.65 (s,
2H, NH2), 3.32 (s, 3H, CH3) ppm. MS, m/z (%): 380 (M
+,
20), 142 (100). Anal. For C19H16N4O3S (380.42) calcd: C
59.99, H 4.24, N 14.37. Found: C 60.02, H 4.39, N 14.10.
2.1.4.4. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-methoxy-
phenyl)-pyrimidin-2-amine (9a). Yield 81%, m.p. 155–7 C.
IR (KBr): m 3300 and 3220 (NH2), 1635 (C‚N), 1545
(C‚C), 1368 and 1157 (SO2), 1010 (CAOAC) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 8.99 (s, 2H,
NH2), 8.22 (s, 1H, H-2 indole), 8.12 (s, 1H, CHApyrimidine),
8.00–7.10 (m, 13H, ArAH), 3.98(s, 3H, OCH3) ppm. Anal. For
C25H20N4O3S (456.52) calcd: C 65.77, H 4.42, N 12.27. Found:
C 65.98, H 4.57, N 12.44.
2.1.4.5. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(p-chloro-
phenyl)-pyrimidin-2-amine (9b). Yield 77%, m.p. 237–
240 C. IR (KBr): m 3220 and 3180 (NH2), 1635 (C‚N),
1565 (C‚C), 1368 and 1157 (SO2), 757 (Cl) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 8.76 (s, 2H, NH2),
8.32 (s, 1H, H-2 indole), 8.21 (s, 1H, CHApyrimidine), 7.98–
7.10 (m, 13H, ArAH) ppm. Anal. For C24H17ClN4O2S
(460.94) calcd: C 62.54, H 3.72, N 12.16. Found: C 62.35, H
3.56, N 12.44.
2.1.4.6. 4-(N-Benzenesulphonyl-1H-indol-3-yl)-6-(m-hydroxy-
phenyl)-pyrimidin-2-amine (9c). Yield 70%, m.p. 233–5 C.
IR (KBr): m 3450 (OH), 3300 and 3218 (NH2), 1645 (C‚N),
1535 (C‚C), 1368 and 1157 (SO2) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 12.01 (s, 1H, OH),
9.21 (s, 2H, NH2), 8.22 (s, 1H, H-2 indole), 8.01 (s, 1H,
CHApyrimidine), 7.87–7.10 (m, 13H, ArAH) ppm. Anal.
For C24H18N4O3S (442.49) calcd: C 65.14, H 4.10, N 12.66.
Found: C 65.32, H 4.22, N 12.56.
2.1.5. Synthesis of N-substituted-3-indolylcyclohexanones 10a–c
and 11a–c
A mixture of chalcones 2a–c or 3a–c (0.01 mol) and ethyl ace-
toacetate (1.30 mL, 0.01 mol) in absolute ethanol (10 mL) con-
taining aqueous potassium hydroxide solution (1 mL, 10%).
The reaction mixture was reﬂuxed for 2 h and then left over-
night at room temperature. The solid that formed was ﬁltered
off, air dried and recrystallized from absolute ethanol.
2.1.5.1. Ethyl-4-(N-methylsulphonyl-1H-indol-3-yl)-6-(p-
methoxyphenyl)-2-oxo-cyclohexa-3-enecarboxylate (10a).
Yield 30%, m.p. 177dec C. IR (KBr): m 1702 and 1688
(C‚O), 1567 (C‚C), 1367 and 1156 (SO2), 1001 (CAOAC)cm1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS):
d = 8.21 (s, 1H, H-2 indole), 7.87–7.01 (m, 8H, ArAH), 6.68
(s, 1H, CH‚C), 4.42 (q, 2H, CH2ACO), 4.12 (s, 3H,
OCH3), 3.65 (s, 3H, CH3), 3.45–2.99 (m, 4H, ACHACHACH2
cyclohexanone), 1.91 (t, 3H, CH3CH2CO) ppm. Anal. For
C25H25NO6S (467.53) calcd: C 64.22, H 5.39, N 3.00. Found:
C 64.45, H 5.45, N 2.89.
2.1.5.2. Ethyl-4-(N-methylsulphonyl-1H-indol-3-yl)-6-(p-chlo-
rophenyl)-2-oxo-cyclohexa-3-enecarboxylate (10b). Yield
32%, m.p. 151–3 C. IR (KBr): m 1703 and 1678 (C‚O),
1577 (C‚C), 1367 and 1156 (SO2), 750 (Cl) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 8.22 (s,
1H, H-2 indole), 7.77–7.01 (m, 8H, ArAH), 6.67 (s, 1H,
CH‚C), 4.44 (q, 2H, CH2ACO), 3.75 (s, 3H, CH3), 3.45–
2.99 (m, 4H, ACHACHACH2 cyclohexanone), 1.61 (t, 3H,
CH3CH2CO) ppm. Anal. For C24H22 ClNO5S (471.95)
calcd: C 61.08, H 4.70, N 2.97. Found: C 61.22, H 4.82,
N 3.01.
2.1.5.3. Ethyl-4-(N-methylsulphonyl-1H-indol-3-yl)-6-(m-
hydroxyphenyl)-2-oxo-cyclohexa-3-enecarboxylate (10c).
Yield 32%, m.p. 211–3 C. IR (KBr): m 3450 (OH), 1712 and
1698 (C‚O), 1557 (C‚C), 1367 and 1156 (SO2) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 10.21 (s, 1H,
OH), 8.21 (s, 1H, H-2 indole), 7.67–7.21 (m, 8H, ArAH),
6.66 (s, 1H, CH‚C), 4.41 (q, 2H, CH2ACO), 3.67 (s, 3H,
CH3), 3.54–2.91 (m, 4H, ACHACHACH2 cyclohexanone),
1.61 (t, 3H, CH3CH2CO) ppm. Anal. For C25H23NO6S
(453.51) calcd: C 63.56, H 5.11, N 3.09. Found: C 63.77, H
5.33, N 3.21.
2.1.5.4. Ethyl-4-(N-benzenesulphonyl-1H-indol-3-yl)-6-(p-
methoxyphenyl)-2-oxo-cyclohexa-3-enecarboxylate (11a).
Yield 32%, m.p. 168–170. IR (KBr): m 1710 and 1698
(C‚O), 1567 (C‚C), 1367 and 1156 (SO2), 1011 (CAOAC)
cm1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS):
d = 8.21 (s, 1H, H-2 indole), 7.87–7.01 (m, 13H, ArAH),
6.68 (s, 1H, CH‚C), 4.42 (q, 2H, CH2ACO), 4.21(s, 3H,
OCH3), 3.55–2.69 (m, 4H, ACHACHACH2 cyclohexanone),
2.91 (t, 3H, CH3CH2CO) ppm. Anal. For C30H27NO6S
(529.60) calcd: C 68.04, H 5.14, N 2.64. Found: C 68.33, H
5.34, N 2.53.
2.1.5.5. Ethyl-4-(N-benzenesulphonyl-1H-indol-3-yl)-6-(p-chlo-
rophenyl)-2-oxo-cyclohexa-3-enecarboxylate (11b). Yield
32%, m.p. 102–4 C. IR (KBr): m 1710 and 1668 (C‚O),
1557 (C‚C), 1367 and 1156 (SO2), 748 (Cl) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 8.11 (s, 1H, H-2 in-
dole), 7.77–7.21 (m, 13H, ArAH), 6.66 (s, 1H, CH‚C), 4.44
(q, 2H, CH2ACO), 3.45–2.89 (m, 4H, ACHACHACH2 cyclo-
hexanone), 2.61 (t, 3H, CH3CH2CO) ppm. MS, m/z (%): 534
(M+, 12), 536 (M++2, 2), 56 (100). Anal. For C29H24ClNO5S
(534.02) calcd: C 65.22, H 4.53, N 2.62. Found: C 65.44, H
4.35, N 2.78.
2.1.5.6. Ethyl-4-(N-benzenesulphonyl-1H-indol-3-yl)-6-(m-
hydroxyphenyl)-2-oxo-cyclohexa-3-enecarboxylate (11c).
Yield 32%, m.p. 122–4 C. IR (KBr): m 3410 (OH), 1722 and
1678 (C‚O), 1577 (C‚C), 1367 and 1156 (SO2) cm
1. 1H
NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.97 (s, 1H,
OH), 8.35 (s, 1H, H-2 indole), 7.97–7.01 (m, 13H, ArAH),
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4H, ACHACHACH2 cyclohexanone), 2.91 (t, 3H,
CH3CH2CO)ppm. MS, m/z (%):515 (M
+, 12), 255 (100).
Anal. For C29H25NO6S (515.58) calcd: C 67.56, H 4.89, N
2.72. Found: C 67.43, H 4.77, N 2.92.
2.1.6. Synthesis of N-substituted-3-indolylindazoles 12a–c and
13a–c
A mixture of compounds 10a–c or 11a–c (0.01 mol) and hydra-
zine hydrate 99% (5 mL, 0.01 mol) in absolute ethanol
(15 mL) containing glacial acetic acid (0.5 mL) was reﬂuxed
for 2 h. After cooling, the solid that formed was ﬁltered off,
air dried and recrystallized from chloroform.
2.1.6.1. 4,5-Dihydro-4-(p-methoxyphenyl)-6-(N-methylsulpho-
nyl-1H-indol-3-yl)-2H-indazol-3(H)one (12a). Yield 51%,
m.p. 220–2 C. IR (KBr): m 3218 (NH), 1665 (C‚O), 1620
(C‚N), 1557 (C‚C), 1367 and 1156 (SO2), 1001 (CAOAC)
cm1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS):
d = 9.50 (s, 1H, NH), 8.12 (s, 1H, H-2 indole), 7.67–7.01 (m,
8H, ArAH), 6.66 (s, 1H, CH‚C), 3.98 (s, 3H, OCH3), 3.88
(s, 3H, CH3), 2.81 and 3.35 (2d, 2H, CHACH) 2.33 and 2.35
(dd, 2H, CH2)ppm. MS, m/z (%):453 (M
+, 3), 144 (100). Anal.
For C23H21N3O4S (435.13) calcd: C 63.43, H 4.86, N 9.65.
Found: C 63.58, H 4.62, N 9.34.
2.1.6.2. 4,5-Dihydro-4-(p-chlorophenyl)-6-(N-methylsulphonyl-
1H-indol-3-yl)-2H-indazol-3(H)one (12b). Yield 48%, m.p.
100–2 C. IR (KBr): m 3218 (NH), 1665 (C‚O), 1620
(C‚N), 1557 (C‚C), 1367 and 1156 (SO2), 752 (Cl) cm
1.
1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.67 (s,
1H, NH), 8.21 (s, 1H, H-2 indole), 7.65–7.00 (m, 8H, ArAH),
6.66 (s, 1H, CH‚C), 3.41 (s, 3H, CH3), 3.32 and 2.81 (2d, 2H,
CHACH), 2.31 and 2.21 (dd, 2H, CH2)ppm. MS, m/z (%):457
(M+, 1), 459 (M++2, 0.2), 65 (100). Anal. For
C22H18ClN3O3S (439.91) calcd: C 60.07, H 4.12, N 9.55.
Found: C 60.22, H 4.30, N 9.31.
2.1.6.3. 4,5-Dihydro-4-(m-hydroxyphenyl)-6-(N-methylsulpho-
nyl-1H-indol-3-yl)-2H-indazol-3(H)one (12c). Yield 51%,
m.p. 144–6 C. IR (KBr): m 3400 (OH), 3218 (NH), 1665
(C‚O), 1620 (C‚N), 1557 (C‚C), 1367 and 1156 (SO2)
cm1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS):
d = 10.51 (s, 1H, OH), 8.57 (s, 1H, NH), 8.12 (s, 1H, H-2 in-
dole), 7.97–7.01 (m, 8H, ArAH), 6.66 (s, 1H, CH‚C), 3.71
(s, 3H, CH3), 2.81 and 3.35 (2d, 2H, CHACH) 2.33 and
2.35 (dd, 2H, CH2) ppm. Anal. For C22H19N3O4S (421.47)
calcd: C 62.69, H 4.54, N 9.97. Found: C 62.33, H 4.75, N
9.63.
2.1.6.4. 4,5-Dihydro-4-(p-methoxyphenyl)-6-(N-benzenesulpho-
nyl-1H-indol-3-yl)-2H-indazol-3(H)-one (13a). Yield 62%,
m.p. 211–3 C. IR (KBr): m 3218 (NH), 1665 (C‚O), 1620
(C‚N), 1557 (C‚C), 1367 and 1156 (SO2), 1001 (CAOAC)
cm1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS):
d = 8.91 (s, 1H, NH), 8.22 (s, 1H, H-2 indole), 7.87–7.01 (m,
13H, ArAH), 6.66 (s, 1H, CH‚C), 3.98 (s, 3H, OCH3), 2.81
and 3.35 (2d, 2H, CHACH) 2.33 and 2.35 (dd, 2H, CHACH2)
ppm. MS, m/z (%): 497 (M+, 3), 142 (100). Anal. For
C28H23N3O4S (497.56) calcd: C 67.59, H 4.66, N 8.45. Found:
C 67.41, H 4.45, N 8.32.2.1.6.5. 4,5-Dihydro-(p-chlorophenyl)-6-(N-benzenesulphonyl-
1H-indol-3-yl)-2H-indazol-3(H)-one (13b). Yield 70%, m.p.
98–100 C. IR (KBr): m 3100 (NH), 1685 (C‚O), 1620
(C‚N), 1567 (C‚C), 1367 and 1156 (SO2), 748 (Cl) cm
1.
1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 9.21 (s,
1H, NH), 8.21 (s, 1H, H-2 indole), 7.76–7.31(m, 13H, ArAH),
6.66 (s, 1H, CH‚C), 3.35 and 2.81 (2d, 2H, CHACH), 2.31
and 2.21 (dd, 2H, CH2)ppm. MS, m/z (%): 501 (M
+, 1), 503
(M++2, 0.2), 77 (100). Ana. For C27H20ClN3O3S
(501.98) calcd: C 64.60, H 4.26, N 8.08. Found: C 62.45, H
4.44, N 8.22.
2.1.6.6. 4,5-Dihydro-(m-hydroxyphenyl)-6-(N-benzenesulpho-
nyl-1H-indol-3-yl)-2H-indazol-3(H)-one (13c). Yield 65%,
m.p. 115–7 C. IR (KBr): m 3420 (OH), 3220 (NH), 1675
(C‚O), 1618 (C‚N), 1557 (C‚C), 1367 and 1156 (SO2) cm
1. 1H NMR (300 MHz, DMSO-d6, 25 C, TMS): d = 12.10
(s, 1H, OH), 8.75 (s, 1H, NH), 8.22 (s, 1H, H-2 indole),
7.97–7.01 (m, 13H, ArAH), 6.76 (s, 1H, CH‚C), 2.81 and
3.35 (2d, 2H, CHACH) 2.33 and 2.35 (dd, 2H, CHACH2)
ppm. Anal. For C27H21N3O4S (483.54) calcd: C 67.07, H
4.38, N 8.69. Found: C 67.25, H 4.52, N 8.32.
2.1.7. Synthesis of N-substituted-3-indolylpyrazoles 14a and 14b
To a solution of compound 2c or 3c (0.01 mol) in absolute eth-
anol (10 mL) containing few drops of glacial acetic acid,
hydrazine hydrate 99% (1 mL, 0.02 mol) was added. The reac-
tion mixture was reﬂuxed for 4 h. After cooling, the reaction
mixture was poured onto ice-water (50 mL), and the solid that
formed was ﬁltered off, air dried and recrystallized from abso-
lute ethanol.
2.1.7.1. 4,5-Dihydro-3-(N-methylsulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-pyrazole (14a). Yield 65%, m.p. 105–
7 C. IR (KBr): m 3340 (OH), 3210 (NH), 1645 (C‚N), 1567
(C‚C), 1376 and 1156 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 12.01 (s, 1H, OH), 8.78 (s, 1H,
NH), 8.21 (s, 1H, H-2 indole), 7.76–7.21 (m, 8H, ArAH),
4.51 (dd, 1H, CHApyrazoline), 3.88 (1H, dd, CH2Apyrazoline
equatorial), 3.44 (dd, 1H, CHApyrazoline axial), 3.22 (s, 3H,
CH3) ppm. Anal. For C18H17N3O3S (355.41) calcd: C 60.83,
H 4.82, N 11.82. Found: C 60.67, H 5.00, N 11.65.
2.1.7.2. 4,5-Dihydro-3-(N-benzenesulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-pyrazole (14b). Yield 75%, m.p. 223–
5 C. IR (KBr): m 3300 (OH), 3100 (NH), 1619 (C‚N), 1566
(C‚C), 1375 and 1156 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 11.01 (s, 1H, OH), 8.57 (s, 1H,
NH), 8.01 (s, 1H, H-2 indole), 7.81–7.01 (m, 13H, ArAH),
4.51 (dd, 1H, CHApyrazoline), 3.98 (1H, dd, CH2Apyrazoline
equatorial), 3.44 (dd, 1H, CHApyrazoline axial) ppm. Anal.
For C23H19N3O3S (417.48) calcd: C 66.17, H 4.59, N 10.07.
Found: C 66.33, H 4.44, N 9.97.
2.1.8. Synthesis of N-substituted-3-indolyl-N-acetylpyrazoles
15a and 15b
Method A: To a solution of compound 2c or 3c (0.01 mol) in a
mixture of (10 mL) acetic anhydride and glacial acetic acid
(2:1) was added hydrazine hydrate 99% (1 mL, 0.02 mol).
The reaction mixture was reﬂuxed for 6–8 h. After cooling,
the reaction mixture was poured onto ice-water (50 mL), and
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lized from aqueous ethanol.
Method B: A mixture of compound 2c or 3c (0.01 mol), ace-
tic acid hydrazide (0.74 g, 0.01 mol) in absolute ethanol
(10 mL) containing glacial acetic acid (0.5 mL) was reﬂuxed
for 2 h. After cooling, the solid that formed was ﬁltered off,
air dried and recrystallized from aqueous ethanol.
2.1.8.1. 4,5-Dihydro-3-(N-methylsulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-acetylpyrazole (15a). Yield 75%, m.p.
178–180 C. IR (KBr): m 3218 (OH), 1678 (C‚O), 1619
(C‚N), 1567 (C‚C), 1367 and 1167 (SO2) cm
1. 1H NMR
spectrum (300 MHz, DMSO-d6, 25 C, TMS): d = 10.05 (s,
1H, OH), 8.23 (s, 1H, H-2 indole), 7.76–7.01 (m, 8H, ArAH),
4.55 (dd, 1H, CHApyrazoline), 3.98 (s, 3H, COCH3), 3.78 (1H,
dd, CH2Apyrazoline equatorial), 3.44 (dd, 1H, CHApyrazo-
line axial), 3.10 (s, 3H, CH3) ppm. Anal. For C20H19N3O4S
(397.45) calcd: C 60.44, H 4.82, N 10.57. Found: C, 60.19, H
5.00, N 10.37.
2.1.8.2. 4,5-Dihydro-3-(N-benzenesulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-acetylpyrazole (15b). Yield 71%, m.p.
201–3 C. IR (KBr): m 3320 (OH), 1688 (C‚O), 1618
(C‚N), 1545 (C‚C), 1357 and 1167 (SO2) cm
1. 1H NMR
(300 MHz, DMSO-d6, 25 C, TMS): d = 11.01 (s, 1H, OH),
8.01 (s, 1H, H-2 indole), 7.81–7.01 (m, 13H, ArAH), 4.51
(dd, 1H, CH-pyrazoline), 3.98 (s, 3H, COCH3), 3.68 (1H,
dd, CH2Apyrazoline equatorial), 3.24 (dd, 1H, CHApyrazo-
line axial) ppm. Anal. For C25H21N3O4S (459.52) calcd: C
65.34, H 4.61, N 9.14. Found: C 65.18, H 4.54, N 19.28.
2.1.9. Synthesis of N-substituted-3-indolyl-N-phenylpyrazoles
16a and 16b
A mixture of compound 2c or 3c (0.01 mol), phenylhydrazine
(1.08 mL, 0.01 mol) in absolute ethanol (10 mL) containing
glacial acetic acid (0.5 mL) was reﬂuxed for 2 h. After cooling,
the solid that formed was ﬁltered off, air dried and recrystal-
lized from absolute ethanol.
2.1.9.1. 4,5-Dihydro-3-(N-methylsulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-phenylpyrazole (16a). Yield 70%,
m.p. 161–3 C. IR (KBr): m 3218 (OH), 1620 (C‚N), 1567
(C‚C), 1367 and 1157 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 11.71(s, 1H, OH), 8.21 (s, 1H,
H-2 indole), 7.67–7.01 (m, 13H, ArAH), 4.56 (dd, 1H,
CHApyrazoline), 3.71 (1H, dd, CH2Apyrazoline equatorial),
3.32 (s, 3H, CH3), 3.21 (dd, 1H, CHApyrazoline axial) ppm.
MS, m/z (%): 431 (M+, 15), 144 (100). Anal. For
C24H21N3O3S (431.51) calcd: C 66.80, H 4.91, N 9.74. Found:
C 67.00, H 5.01, N 9.54.
2.1.9.2. 4,5-Dihydro-3-(N-benzenesulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-phenylpyrazole (16b). Yield 55%,
m.p. 179–181 C. IR (KBr): m 3320 (OH), 1635 (C‚N), 1545
(C‚C), 1357 and 1157 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 12.51(s, 1H, OH), 8.21 (s, 1H,
H-2 indole), 7.56–7.00 (m, 18H, ArAH), 4.55 (dd, 1H,
CHApyrazoline), 3.66 (1H, dd, CH2Apyrazoline equatorial),
3.32 (dd, 1H, CHApyrazoline axial) ppm. MS, m/z (%): 493
(M+, 7), 142 (100). Anal. For C29H23N3O3S (493.58) calcd:
C 70.57, H 4.70, N 8.51. Found: C 70.43, H 4.57, N 8.65.2.1.10. Synthesis of N-substituted-3-indolyl- N-benzylpyrazoles
17a and 17b
A mixture of compound 2c or 3c (0.01 mol), benzylhydrazine
hydrochloride (1.95 g, 0.01 mol), anhydrous sodium acetate
(0.67 g, 0.02 mol) in dry ethanol (15 mL) was reﬂuxed for 2–
3 h. After cooling, the solid that formed was ﬁltered off, air
dried and recrystallized from absolute ethanol.
2.1.10.1. 4,5-Dihydro-3-(N-methylsulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-benzylpyrazole (17a). Yield 55%,
m.p. 87–9 C. IR (KBr): m 3100 (OH), 1622 (C‚N), 1547
(C‚C), 1367 and 1167 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 12.05 (s, 1H, OH), 8.23 (s, 1H,
H-2 indole), 7.76–7.01 (m, 13H, ArAH), 5.56 (s, 2H, NACH2),
4.55 (dd, 1H, CHApyrazoline), 3.78 (dd, 1H, CH2Apyrazoline
equatorial), 3.44 (dd, 1H, CH2Apyrazoline axial), 3.10 (s, 3H,
CH3) ppm. Anal. For C25H23N3O3S (445.53) calcd: C 67.40, H
5.20, N 9.43. Found: C 67.56, H 5.37, N 9.65.
2.1.10.2. 4,5-Dihydro-3-(N-benzenesulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-N-benzylpyrazole (17b). Yield 64%, m.p.
148–150 C. IR (KBr): m 3212 (OH), 1645 (C‚N), 1555
(C‚C), 1357 and 1151 (SO2) cm
1. 1H NMR (300 MHz,
DMSO-d6, 25 C, TMS): d = 11.01 (s, 1H, OH), 8.01 (s, 1H,
H-2 indole), 7.91–7.01 (m, 18H, ArAH), 5.56 (s, 2H, NACH2),
4.51 (dd, 1H, CHApyrazoline), 3.68 (1H, dd, CH2Apyrazoline
equatorial), 3.24 (dd, 1H, CHApyrazoline axial) ppm. Anal.
For C30H25N3O3S (507.60) calcd: C 70.98, H 4.96, N 8.28.
Found: C 71.01, H 5.02, N 8.11.
2.1.11. Synthesis of N-substituted-3-indolylisoxazoles 18a and
18b
To a solution of compounds 2c and 3c (0.01 mol) in absolute
ethanol (10 mL) were added hydroxylamine hydrochloride
(0.69 g, 0.01 mol) and anhydrous sodium acetate (0.67 g,
0.01 mol). The reaction mixture was reﬂuxed for 6–8 h. After
cooling, the reaction mixture was poured onto ice-water
(50 ml) and the solid that formed was ﬁltered off, air dried
and recrystallized from absolute ethanol.
2.1.11.1. 4,5-Dihydro-3-(N-methylsulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-isoxazole (18a). Yield 70%, m.p. 168–
170 C. IR (KBr): m 3218 (OH), 1626 (C‚N), 1557 (C‚C),
1367 and 1147 (SO2) cm
1. 1H NMR (300 MHz, DMSO-
d6, 25 C, TMS): d = 12.23 (s, 1H, OH), 8.22 (s, 1H, H-2 in-
dole), 7.78–7.01 (m, 8H, ArAH), 4.51 (dd, 1H, CHAisoxaz-
ole), 3.78 (1H, dd, CH2Aisoxazole equatorial), 3.56 (dd,
1H, CHAisoxazole axial), 3.31 (s, 3H, CH3)ppm. MS, m/z
(%): 356 (M+, 20), 144 (100). Anal. For C18H16N2O4S
(356.40) calcd: C 60.66, H 4.53, N 7.86. Found: C 60.88, H
4.42, N 7.64.
2.1.11.2. 4,5-Dihydro-3-(N-benzenesulphonyl-1H-indol-3-yl)-5-
(m-hydroxy-phenyl)-isoxazole (18b). Yield 70%, m.p. 145–
7 C. IR (KBr): m 3200 (OH), 1615 (C‚N), 1545 (C‚C),
1357 and 1157 (SO2) cm
1. 1H NMR (300 MHz, DMSO-d6,
25 C, TMS): d = 11.77 (s, 1H, OH), 8.21 (s, 1H, H-2 indole),
7.54–7.07 (m, 13H, ArAH), 4.54 (dd, 1H, CHAisoxazole), 3.87
(1H, dd, CH2Aisoxazole equatorial), 3.41 (dd, 1H, CHAisox-
azole axial)ppm. MS, m/z (%): 418 (M+, 1), 144 (100). Anal.
For C23H18N2O4S (418.47) calcd: C 66.01, H 4.34, N 6.69.
Found: C 66.22, H 4.50, N 6.54.
Synthesis, antimicrobial and anticancer activities of some new N-methylsulphonyl 732.2. Antimicrobial evaluation
The antimicrobial activity of the newly synthesized compounds
was determined in vitro using the disk diffusion method (Bauer
et al., 1966) against a variety of pathogenic microorganisms:
Salmonella typhimurium (ATCC 14028), Pseudomonas ﬂuores-
cens (S 97) (Gram-positive bacteria), Staphylococcus aureus
(ATCC 25923), Bacillus subtilis (ATCC 6635) (Gram-negative
bacteria) and two strains of fungi Candida albicans (ATCC
10231) and Aspergillus fumigatus (isolated from clinical sam-
ples and identiﬁed to the species level according to different
API 20E system (Analytab Products) (bioMerieux, Australia).
The antimicrobial activities of the tested compounds were esti-
mated by placing presterilized ﬁlter paper disks (6 mm in diam-
eter) impregnated with 20 and 10 lg disk1 in Nutrient and
MacConky agar media for bacteria and on Sabouraud dex-
trose agar for fungus. Dimethyl formamide (DMF) which
showed no inhibition zone was used as a solvent for impregna-
tion. The inhibition zones (IZ) of the tested compounds were
measured after 24–48 h incubation at 37 C for bacteria and
after 5 days incubation at 28 C for fungi. Chloramphenicol
(C1863, Sigma–Aldrich) and cephalothin (C3050, Sigma–Al-
drich) were used as reference drugs for bacteria. Whereas,
cycloheximide (C7698, Sigma–Aldrich) was used as reference
drug for fungi.2.3. Anticancer evaluation
2.3.1. Cell culture
HEPG2 (human Liver carcinoma),MCF7 (Human Breast Can-
cer) and HCT-116 (Human Colon Cancer) cell lines were ob-
tained from Karolinska Institute, Stockholm, Sweden. All
cells weremaintained inRPMI 1640 (LonzaBiowahittkar)med-
ium, except for MCF7 cancer cells that were maintained in
DMEMmedium (Lonza Biowahittkar). All themedia were sup-
plemented with 1% antibiotic–antimycotic mixture (10,000 U
per mL Potassium Penicillin (Biowest), 10,000 lg mL1 Strep-
tomycin Sulfate (Biowest), 25 lg mL1 Amphotericin B
(Biowest) and 1% L-glutamine (Biowest).2.3.2. MTT cytotoxicity assay
The cell viability was investigated using MTT [3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (Mos-
mann, 1983). This reaction depends on the mitochondrial
dependant reduction of yellow MTT into purple formazan.
All the preceding steps were carried out in sterile laminar air
ﬂow cabinet Biosafty class II level (Baker, SG403INT, San-
ford, ME, USA). All incubations were done at 37 C in 5%
CO2 incubator in humidiﬁed atmosphere (Sheldon, TC2323,
Cornelius, OR, USA). Cells were seeded into 96-well microtiter
plastic plates at the concentration of (104 cells per well) and al-
lowed to adhere for 24 h. Media were aspirated and fresh med-
ium (without serum) was added to the cells with various
concentrations of the tested compounds (10, 5, 2.5 and
1.25 lg mL1) and incubated for 48 h. For the untreated cells
(negative control), media were added instead of the tested
compounds. A positive control Adrinamycin (Doxorubicin)
[Mw= 579.99] was used as a known cytotoxic natural agent
which gives 100% inhibition. Medium was aspirated and
40 lL MTT salt (2.5 lg mL1) (Biobasic Inc) was added to
each well and incubated for further 4 h. To stop the reactionand dissolve any formed formazan crystals, 200 lL of 10% so-
dium dodicyl sulfate (SDS) was added to each well and incu-
bated overnight at 37 C. The amount of formazan product
was measured at 595 nm and a reference wave length of
620 nm as a background using a microplate reader (Bio-Rad
Laboratories Inc., model 3350, Hercules, California, USA).
The percentage of change in viability was calculated according
to the formula:
Absorbance of tested compounds
Absorbance of negative control
 
 1 100
A statistical signiﬁcance was tested between samples and neg-
ative control (cells with vehicle) using independent t-test by
SPSS 11 program. Dimethyl Sulfoxide (DMSO) is the vehicle
used for dissolution of tested compound and its ﬁnal concen-
tration on the cells was less than 0.2%. A probate analysis
was carried out for IC50 determination using SPSS 11 program3. Results and discussion
3.1. Chemistry
The reaction routes for the synthesis of the title compoundswere
described, as shown in Schemes 1 and 2. Claisen–Schmidt reac-
tion of N-methylsulphonyl-3-acetylindole (1a) and N-benzene-
sulphonyl-3-acetylindole (1b) with some aromatic aldehydes
namely, p-methoxy, p-chloro or m-hydroxybezaldehydes in
ethanol in the presence of aqueous potassium hydroxide
(25%) led to the formation of 1-(N-methylsulphonyl-1
H-indol-3-yl)-3-aryl-prop-2-ene-1-ones (2a–c) and 1-(N-ben
zenesulphonyl-1H-indol-3-yl)-3-aryl-prop-2-ene-1-ones (3a–c),
respectively (Scheme 1). Compounds 2a,b and 3a,b are previ-
ously reported (El-Sawy et al., 2009), and the newly compounds
2c and 3cwere conﬁrmed by their correct elemental analyses and
spectral data (c.f. Experimental section).
Cyclocondensation of chalcones 2a–c or 3a–c with urea in
dry ethanol in the presence of glacial acetic acid as a catalyst
gave 4-(N-substituted-1H-indol-3-yl)-6-aryl-pyrimidin-2(1H)-
ones (4a–c) and (5a–c), respectively (Scheme 1). Similarly,
chalcones 2a–c or 3a–c reacted with thiourea and gave the cor-
responding 4-(N-substituted-1H-indol-3-yl)-6-aryl-pyrimidin-
2(1H)-thiones (6a–c) and (7a–c), respectively (Scheme 1).
Moreover, reaction of chalcones 2a–c or 3a–c with guanidine
hydrochloride in dry ethanol in the presence of anhydrous so-
dium acetate yielded 4-(N-substituted-1H-indol-3-yl)-6-aryl-
pyrimidin-2-amines (8a–c) and (9a–c), respectively (Scheme 1).
It was reported that, reaction of chalcone with ethyl aceto-
acetate in the presence of aqueous potassium hydroxide
(10%) gives rise to cyclohexanone (Sreevidya et al., 2010). In
the present work and under the above mentioned conditions,
chalcones 2a–c or 3a–c reacted with ethyl acetoacetate (1:1)
and gave the newly compounds namely, ethyl-4-(N-substi-
tuted-1H-indol-3-yl)-6-aryl-2-oxo-cyclohexa-3-enecarboxy-
lates (10a–c) and (11a–c), respectively (Scheme 1).
Reaction of compound 10a with hydrazine hydrate under
reﬂux in absolute ethanol in the presence of glacial acetic acid
as a catalyst afforded 12a. Its IR spectrum showed absorption
band at 3218, 1665, 1620 for NH, C‚O and C‚N groups suc-
cessively. Its 1H NMR (DMSO-d6) lacks the signals at d 4.48
and 1.69 ppm of COOCH2CH3 and showed 1H, singlet signal
(D2O exchangeable) at d 9.50 ppm which can be attributed to
74 E.R. El-Sawy et al.the proton of NH group besides the signals at d 8.12 (s, 1H, H-
2 indole), 7.67–7.01 (m, 8H, ArAH), 6.66 (s, 1H, CH‚C), 3.98
(s, 3H, OCH3), 3.88 (s, 3H, CH3), 2.81 and 3.35 (2d, 2H,
CHACH) 2.33 and 2.35 ppm (dd, 2H, CHACH2). Its mass
spectrum showed a molecular ion peak at m/z 453 (3%) (c.f.
Experimental section). The structure of compound 12a was
actually identiﬁed by the IR, 1H NMR and MS spectra as,N
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Scheme 1 Synthetic route for the preparation of N-substituted sulpho4,5-dihydro-4-(p-methoxyphenyl)-6-(N-methylsulphonyl-1H-
indol-3-yl)-2H-indazol-3(H)one (Scheme S1). The reaction
may be proceded through condensation between C‚O of
cyclohexanone and NH2 of hydrazine, followed with cycliza-
tion by loosing a molecule of ethanol. Similarly, reaction of
10b,c or 11a–c with hydrazine hydrate under the above men-
tion condition led to the formation of 4,5-dihydro-4-aryl-6-Ar
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(12b,c) and (13a–c), respectively (Scheme 1) (See Scheme S2).
On the other hand, condensation of chalcones 2c or 3c with
hydrazine hydrate in absolute ethanol in the presence of
few drops of glacial acetic acid gave 4,5-dihydro-3-(N-substi-
tuted-1H-indol-3-yl)-5-(m-hydroxy-phenyl)pyrazoles (14a)
and (14b), respectively (Scheme 2). whereas, reaction of 2c or
3c with hydrazine hydrate under reﬂux in a mixture of acetic
anhydride and glacial acetic acid (2:1) afforded the
corresponding N-acetylpyrazole derivatives 15a and 15b
(Scheme 2). Incidentally, compounds 15a and 15b were ob-
tained via the reaction of 2c and 3c with acetic acid hydrazide
in reﬂuxing ethanol which showed no depression in a dmixed
m.p.s with that previously obtained (Scheme 2).
Additionally, reaction of 2c or 3c with phenylhydrazine
gave N-phenylpyrazole derivatives 16a and 16b. While, reac-
tion of 2c or 3c with benzylhydrazine hydrochloride in the
presence of anhydrous sodium acetate gave N-benzylpyrazole
derivatives 17a and 17b (Scheme 2).
Moreover, reaction of 2c or 3c with hydroxyl amine hydro-
chloride in the presence of anhydrous sodium acetate led to theN
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Scheme 2 Synthetic route of the preparation of N-substituted sulphon
R, a=CH3; b= Ph.formation of 4,5-dihydro-3-(N-substituted-1H-indol-3-yl)-5-
(m-hydroxyphenyl)isoxazoles (19a) and (19b) (Scheme 2).
The structures of the newly synthesized compounds were
conﬁrmed on the bases of elemental analyses as well as spectral
data (IR, 1HNMR, andMS spectra) (c.f. Experimental section).
3.2. Antimicrobial activity
All the newly synthesized compounds were tested for their
antimicrobial activities against a variety of pathogenic
microorganisms: S. typhimurium (ATCC 14028), P. ﬂuorescens
(S 97) (Gram-positive bacteria), S. aureus (ATCC 25923), B.
subtilis (ATCC 6635) (Gram-negative bacteria) and two strains
of fungi C. albicans (ATCC 10231) and A. fumigatus (isolated
from clinical samples and identiﬁed to the species level accord-
ing to different API 20E system (Analytab Products) (bio-
Merieux, Australia) using the disk diffusion method at
concentrations of 10 and 20 lg disk1 (Table 1). The results
showed that, compounds 14a, 14b, 15a and 15b were found
to be the most active of all the tested compounds, with inhibi-
tion zones of 30, 35, 31 and 30 mm, respectively, against S.N
SO2R
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N
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N
N
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N
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4
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yl-3-indolyl pyrazole and isoxazole derivatives; compounds 14–18,
Table 1 Antimicrobial activitya of the newly synthesized compounds.
Compd.
no.
Inhibition zone (mm)
Gram-positive bacteria Gram-negative bacteria Fungi
S. typhimurium
(ATCC 14028)
P. ﬂuorescens (S
97)
S. aureus (ATCC
25923)
B. subtilis (ATCC
6635)
C. albicans (ATCC
10231)
A.
fumigatusb
Concentration lg
20 10 20 10 20 10 20 10 20 10 20 10
4a 14 9 14 9 14 9 14 9 – – – –
4b 14 9 14 9 14 9 14 9 – – – –
4c 14 9 14 9 14 9 14 9 – – – –
5a 14 9 14 9 14 9 14 9 – – – –
5b 14 9 14 9 14 9 14 9 – – – –
5c 14 9 14 9 14 9 14 9 – – – –
6a 14 9 14 9 14 9 14 9 – – – –
6b 14 9 14 9 14 9 14 9 – – – –
6c 14 9 14 9 14 9 14 9 – – – –
7a 14 9 14 9 14 9 14 9 – – – –
7b 14 9 14 9 14 9 14 9 – – – –
7c 14 9 14 9 14 9 14 9 – – – –
8a 17 8 17 8 14 9 14 9 – – – –
8b 17 8 17 8 14 9 14 9 – – – –
8c 17 8 17 8 14 9 14 9 – – – –
9a 17 8 17 8 14 9 14 9 – – – –
9b 17 8 17 8 14 9 14 9 – – – –
9c 17 8 17 8 14 9 14 9 – – – –
10a 17 8 17 8 14 9 14 9 – – – –
10b 17 8 17 8 14 9 14 9 – – – –
10c 17 8 17 8 14 9 14 9 – – – –
11a 17 8 17 8 14 9 14 9 – – – –
11b 17 8 17 8 14 9 14 9 – – – –
11c 17 8 17 8 14 9 14 9 – – – –
12a – – – – – – – – – – – –
12b – – – – – – – – – – – –
12c – – – – – – – – – – – –
13a – – – – – – – – – – – –
13b – – – – – – – – – – – –
13c – – – – – – – – – – – –
14a 30 20 28 19 17 9 20 11 – – – –
14b 35 20 26 19 17 9 20 11 – – – –
15a 31 20 27 19 17 9 21 11 – – – –
15b 30 20 26 19 17 9 21 11 – – – –
16a 28 18 28 18 18 10 22 11 – – – –
16b 28 18 28 18 18 10 22 11 – – – –
17a 27 17 26 17 18 10 20 11 – – – –
17b 27 17 26 17 18 10 20 11 – – – –
18a – – – – – – – – – – – –
18b – – – – – – – – – – – –
Stander
a
42 28 37 31 – – – – – – – –
Stander
b
– – – – 38 29 38 30 – – – –
Stander
c
– – – – – – – – 39 28 40 31
Stander a: chloramphenicol; reference drug for Gram-positive bacteria; stander b: cephalothin; reference drug for Gram-negative bacteria;
stander c: cycloheximide; reference drug for fungi.
a Disk diffusion method.
b Isolated from clinical samples and identiﬁed to the species level according to different API 20E system (Analytab Products) (bioMerieux,
Australia).
76 E.R. El-Sawy et al.typhimurium (ATCC 14028) compared to the reference drug
chloramphenicol (42 mm) at 20 lg disk1, and showed inhibi-
tion zones of 20 mm against S. typhimurium (ATCC 14028)compared to the reference drug chloramphenicol (28 mm) at
10 lg disk1. The rest of the tested compounds were non-ac-
tive against all microorganisms (Table 1).
Table 2 Anticancer screening of the eighteen new synthesized
compounds against human liver (HEPG2), human breast
(MCF7) and human colon carcinoma (HCT-116) cell lines at
a concentration of 10 lg ml1.
Compd.
no.
HEPG-2 MCF7 HCT-116
Inhibition growth %
4a 63.5 47.3 43.0
4b 63.5 26.7 37.6
4c 99.6 100.7 100.0
5a 36.1 35.0 16.4
5b 3.1 50.9 11.5
5c 94.3 84.6 97.4
6a 24.8 14.3 26.0
6b 16.23 23.2 19.5
6c 94.2 99.0 100.3
7a 65.1 23.2 23.8
7b 19.5 13.7 4.8
7c 70.3 73.9 85.4
8a 46.0 64.2 28.1
8b 51.6 32.8 27.8
8c 95.1 100.3 99.3
9a 37.0 35.0 43.5
9b 22.6 18.9 14.9
9c 96.3 85.0 90.1
Table 3 IC50 of the highly cytotoxic active compounds
against human liver carcinoma (HEPG2), human breast cancer
(MCF7) and human colon cancer (HCT-116) cell lines.
Compd. no. IC50 (lg/ml)
HEPG2 MCF7 HCT-116
4c 1.6 2.1 3.7
5c 2.9 – 5.1
6c 3.1 2.6 4.7
8c 2.4 1.8 3.5
9c 1.7 – 2.8
Doxorubicin 24.47 38.2 37.6
IC50: compound concentration required to inhibit the cell viability
by 50%.
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Eighteen new compounds namely, pyrimidin-2(1H)-ones 4a–c
and 5a–c, pyrimidin-2(1H)-thiones 6a–c and 7a–c and
pyrimidin-2-amines 8a–c and 9a–c were primary screened for
their in vitro cytotoxicity against (HEPG2), (MCF7)
and (HCT-116) cell lines at a concentration of 10 lg mL1
(Table 2). Compounds 4c, 6c and 8c were found to be the
highly active compounds with cytotoxicity of 99.6, 94.2 and
95.1%, respectively, against HEPG2, and showed activity of
100.7, 99.0 and 100.3%, respectively, against MCF7 and also,
showed activity of 100.0, 100.3 and 99.3%, respectively,
against HCT-116. While, compounds 5c and 9c showed activ-
ity of 94.3 and 96.3%, respectively, against HEPG2 and
showed activity of 97.4 and 90.1%, respectively, against
HCT-116 (Table 2).
The compounds that gave cytotoxicity more than 90% at
10 lg mL1 were used to calculate their IC50 value, which cor-responds to the concentration required for 50% inhibition of
all cell viability. Doxorubicin is one of the most effective anti-
cancer agents used as reference drug (Table 3). In case of
HEPG2 cancer cell line, compounds 4c, 5c, 6c, 8c and 9c
showed more potent activity with IC50 = 1.6, 2.9, 3.1, 2.4
and 1.7 lg mL1, respectively, than the reference drug doxoru-
bicin (IC50 = 24.47 lg mL
1). In case of MCF7 cancer cell
line, compounds 4c, 6c and 8c showed more potent activity
with IC50 = 201, 2.6 and 1.8 lg mL
1, respectively, than the
reference drug doxorubicin(IC50 = 38.2 lg mL
1) (Table 3).
In case of HCT-116 cancer cell line, compounds 4c, 5c, 6c,
8c and 9c showed more potent activity with IC50 = 3.7, 5.1,
4.7, 3.5 and 2.8 lg mL1, respectively, than the reference drug
doxorubicin (IC50 = 37.6 lg mL
1) (Table 3).
Interpretation of the obtained results and considering the
structure activity relationship (SAR) of the tested compounds
showed that, compounds 4c, 5c, 6c, 8c and 9c that contain hy-
droxyl group at p-position of phenyl moiety at pyrimidine ring
are associated with remarkable cytotoxicity against all cancer
cell lines under investigation HEPG2, MCF7 and HCT-116.4. Conclusion
A new series of pyrimidin-2(1H)ones 4a–c and 5a–c, pyrimi-
din-2(1H)-thiones 6a–c and 7a–c, pyrimidin-2-amines 8a–c
and 9a–c, cyclohexanones 10a–c and 11a–c, indazoles 12a–c
and 13a–c, pyrazoles 14a,b–17a,b and isoxazoles 18a,b deriva-
tives incorporated to N-substituted sulphonyl indoles at their
3-positions were prepared. The newly synthesized compounds
were tested for their in vitro antimicrobial and anti-cancer
activities, and interpretation of the obtained results with con-
sidering the structure activity relationship (SAR) of the tested
compounds showed that:
1. Compounds 14a, 14b, 15a and 15b which contain pyrazole
ring at 3-position of N-substituted sulphonyl indole were
found to be the most active of all the tested compounds
toward S. typhimurium (ATCC 14028) compared to the ref-
erence drug chloramphenicol.
2. Compounds 4c, 5c, 6c, 8c and 9c that contain hydroxyl
group at p-position of phenyl moiety at pyrimidine ring
are associated with remarkable cytotoxicity against all can-
cer cell lines under investigation HEPG2, MCF7 and HCT-
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